Rui Yi

Anaphore is developing protein pharmaceuticals to address significant unmet medical needs for patients with serious diseases. RuiYi is a Wholly Foreign-Owned Enterprise (WFOE) located in the Zhangjiang Hi-Tech Park in Pudong Shanghai, China. RuiYi is developing biologic therapies that target G protein coupled receptors (GPCRs).